Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Clinics and Research in Hepatology and Gastroenterology|July 16, 2023
Efficacy of robot-assisted vs. laparoscopy surgery in the treatment of colorectal cancer: A systematic review and meta-analysisLeilei Yang, Chengfeng Fang, Tienan Bi, et al.BMC Gastroenterology|April 11, 2025
The effectiveness of treatment with probiotics in preventing necrotizing enterocolitis and related mortality: results from an umbrella meta-analysis on meta-analyses of randomized controlled trialsJiaju Han, Yufeng Ren, Peini Zhang, et al.Human Vaccines & Immunotherapeutics|September 12, 2025
The construction of a prognostic nomogram model for colorectal cancer and the prediction of immune characteristics and immune treatment responses based on the bioinformatics analysis of soluble mediator-related genesLeilei Yang, Xiuying Yang, Chengfeng Fang, et al.Journal of Biochemical and Molecular Toxicology|March 7, 2025
SALL4/ABCB6 Axis Suppresses Ferroptosis in Colon Cancer by Mediating MitophagyLeilei Yang, Yuehuai Xu, Jiaju Han, et al.Journal of Applied Genetics|August 2, 2025
Identification of colorectal cancer molecular subtypes and prognostic features based on basement membrane-related genesLeilei Yang, Zhiqing Ji, Yufeng Ren, et al.International Journal of Clinical and Experimental Medicine|April 23, 2014
APOBEC3G expression is correlated with poor prognosis in colon carcinoma patients with hepatic metastasisHuanrong Lan, Ketao Jin, Meifu Gan, et al.Molecular Medicine (Cambridge, Mass.)|November 16, 2024
CKS2 induces autophagy-mediated glutathione metabolic reprogramming to facilitate ferroptosis resistance in colon cancerLeilei Yang, Chengfeng Fang, Jiaju Han, et al.American Journal of Translational Research|December 27, 2021
Deubiquitination and Stabilization of PD-L1 by USP21Shuying Yang, Huanhuan Yan, Youqian Wu, et al.Therapeutic Advances in Medical Oncology|July 14, 2025
Camrelizumab plus SOX chemotherapy as adjuvant therapy for pathological stage III gastric or gastroesophageal junction adenocarcinoma: a prospective, multicenter, single-arm, phase II trialHailong Jin, Jiren Yu, Yuan Gao, et al.Pageof 3